
JSP-3-RT
$55.00 – $95.00 · 3 sizes
Triple GIP/GLP-1/glucagon receptor agonist research compound for multi-receptor metabolic signaling studies.
- Purity
- >99%
- Testing
- 3rd-party
- Shipping
- Tracked, discreet
16 lab reports (COA) available for this product.
About JSP-3-RT
Next-generation triple receptor agonism. Engineered for the frontier of metabolic research.
JSP-3-RT is a synthetic peptide engineered as a triagonist of the GLP-1, GIP, and glucagon receptors — representing one of the most advanced compounds in contemporary metabolic peptide research. Unlike dual agonists, JSP-3-RT's simultaneous engagement of all three receptor pathways has positioned it as a subject of intense scientific interest for its potential role in energy homeostasis, adipose tissue regulation, and glycemic control.
Research applications
- Triple receptor agonism — GLP-1, GIP, and glucagon pathways
- Adipose tissue regulation and energy expenditure research
- Glycemic homeostasis and insulin sensitivity mechanisms
- Appetite signaling and satiety pathway investigation
- Cardiovascular metabolic marker research
Lab reports (COA)
Independent third-party test results for JSP-3-RT, newest first.
| Batch | Size | Tested | Lab | Purity | Report |
|---|---|---|---|---|---|
| 030030BT | 30mg | Sep 11, 2026 | Freedom Diagnostics (HGTC group test) | 99.77% | View COA |
| HGTC0002WT | 20mg | Aug 20, 2026 | Freedom Diagnostics (HGTC group test) | 99.81% | View COA |
| Lab #209185 | 30mg | Jul 17, 2026 | Krause Analytical (group test) | >99.9% | View COA |
| Lab #209187 | 30mg | Jul 17, 2026 | Krause Analytical (group test) | >99.9% | View COA |
| Lab #209184 | 30mg | Jul 17, 2026 | Krause Analytical (group test) | >99.9% | View COA |
| emma-orlando-blue | 20mg | May 26, 2026 | Krause Analytical (group test) | >99.9% | View COA |
| blue/clearcap | 10mg | May 26, 2026 | Krause Analytical (group test) | >99.9% | View COA |
| David/Emma | 20mg | May 26, 2026 | Krause Analytical (group test) | >99.9% | View COA |
| BTL26243-01 | 20mg | Apr 17, 2026 | BTLabs (group test) | 99.7% | View COA |
| BTL26206-02 | 30mg | Apr 14, 2026 | BTLabs (group test) | 99.6% | View COA |
| BTL26204-01 | 10mg | Apr 14, 2026 | BTLabs (West Palm Beach, FL) | 99.5% | View COA |
| BTL26181-04 | 20mg | Apr 9, 2026 | BTLabs (West Palm Beach, FL) | 99.6% | View COA |
| BTL26170-01 | 20mg | Apr 8, 2026 | BTLabs (West Palm Beach, FL) | 99.7% | View COA |
| SPRI-XJR103-52326 | 10mg | — | Freedom Diagnostics (supplier lot test) | 99.85% | View COA |
| Mi092026 | 30mg | — | ILS Laboratories (group test) | 99.66% | View COA |
| Client AA | 20mg | — | Freedom Diagnostics (group test) | 99.95% | View COA |



